BIGNUCOLO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 977
AS - Asia 748
EU - Europa 321
SA - Sud America 141
AF - Africa 130
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 8
Totale 2.348
Nazione #
US - Stati Uniti d'America 903
SG - Singapore 284
CN - Cina 165
BR - Brasile 93
HK - Hong Kong 80
VN - Vietnam 49
IT - Italia 45
DE - Germania 40
PL - Polonia 31
FI - Finlandia 27
RU - Federazione Russa 17
GB - Regno Unito 14
IN - India 14
FR - Francia 13
TR - Turchia 13
MN - Mongolia 12
BJ - Benin 11
CA - Canada 11
ZA - Sudafrica 11
EC - Ecuador 10
SE - Svezia 10
HR - Croazia 9
AR - Argentina 8
IQ - Iraq 8
NL - Olanda 8
TW - Taiwan 8
UA - Ucraina 8
UY - Uruguay 8
AZ - Azerbaigian 7
BE - Belgio 7
DZ - Algeria 7
PK - Pakistan 7
TH - Thailandia 7
TJ - Tagikistan 7
AU - Australia 6
BD - Bangladesh 6
CR - Costa Rica 6
JP - Giappone 6
MX - Messico 6
NC - Nuova Caledonia 6
PH - Filippine 6
AM - Armenia 5
AT - Austria 5
BY - Bielorussia 5
CH - Svizzera 5
CW - ???statistics.table.value.countryCode.CW??? 5
DO - Repubblica Dominicana 5
EE - Estonia 5
ES - Italia 5
GF - Guiana Francese 5
GT - Guatemala 5
IE - Irlanda 5
JO - Giordania 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PA - Panama 5
RE - Reunion 5
RO - Romania 5
TZ - Tanzania 5
AD - Andorra 4
AE - Emirati Arabi Uniti 4
CD - Congo 4
CY - Cipro 4
GH - Ghana 4
HT - Haiti 4
ID - Indonesia 4
IL - Israele 4
IR - Iran 4
IS - Islanda 4
KH - Cambogia 4
KR - Corea 4
LT - Lituania 4
LY - Libia 4
MA - Marocco 4
MD - Moldavia 4
MK - Macedonia 4
MU - Mauritius 4
MW - Malawi 4
NO - Norvegia 4
NP - Nepal 4
PG - Papua Nuova Guinea 4
PR - Porto Rico 4
RS - Serbia 4
TL - Timor Orientale 4
TN - Tunisia 4
VC - Saint Vincent e Grenadine 4
ZM - Zambia 4
AO - Angola 3
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CG - Congo 3
CI - Costa d'Avorio 3
CL - Cile 3
CM - Camerun 3
CO - Colombia 3
CU - Cuba 3
CV - Capo Verde 3
CZ - Repubblica Ceca 3
Totale 2.237
Città #
Singapore 152
Ashburn 146
Fairfield 107
Chandler 90
Hong Kong 74
Beijing 63
Cambridge 40
Seattle 38
Santa Clara 36
Woodbridge 34
Los Angeles 25
Bytom 22
Houston 22
Boardman 21
Wilmington 21
Munich 19
Padova 16
Medford 15
New York 15
Princeton 15
Helsinki 14
Hanoi 13
Des Moines 12
Ulan Bator 12
Cotonou 11
Chicago 9
Ho Chi Minh City 9
San Diego 9
Ann Arbor 8
Da Nang 7
London 7
Warsaw 7
Baku 6
Buffalo 6
Cagliari 6
Falkenstein 6
Noumea 6
Philadelphia 6
Roxbury 6
Turku 6
Albignasego 5
Dallas 5
Dushanbe 5
Hefei 5
Jinan 5
Lappeenranta 5
Melbourne 5
Montevideo 5
San José 5
São Paulo 5
Yerevan 5
Accra 4
Andorra la Vella 4
Atlanta 4
Bangkok 4
Chisinau 4
Dar es Salaam 4
Dili 4
Istanbul 4
Johannesburg 4
Kingstown 4
Lahore 4
Lusaka 4
Madrid 4
Nanjing 4
New Delhi 4
Orem 4
Panama City 4
Phoenix 4
Port Moresby 4
San Juan 4
Stockholm 4
Tokyo 4
Toronto 4
Vientiane 4
Willemstad 4
Zagreb 4
Abidjan 3
Amman 3
Atglen 3
Auckland 3
Baghdad 3
Belo Horizonte 3
Bridgetown 3
Brooklyn 3
Cape Town 3
Cayenne 3
Conakry 3
Denver 3
Douala 3
Dublin 3
George Town 3
Guatemala City 3
Guayaquil 3
Harare 3
Havana 3
Kampala 3
Kharkiv 3
Kinshasa 3
Libreville 3
Totale 1.365
Nome #
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 153
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 153
Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy 145
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 137
PREEMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS (PREPARE): STATE OF ART AND PRELIMINARY RESULTS ON GENOTYPE ACTIONABILITY 136
Resveratrol in cancer patients: From bench to bedside 127
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 126
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 124
Development of an Integrated Health IT Platform for a Precision Medicine Setting 124
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 123
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 118
Integrative oncology: evidence-based medicine - The multidisciplinary experience of the Integrative Medicine Research Group (IMRG) 109
Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results 107
Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity 103
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 103
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 103
Sex disparities in efficacy in covid-19 vaccines: A systematic review and meta-analysis 98
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 95
The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies 94
Uso di marcatori farmacogenetici per migliorare la sicurezza e l'efficacia dei trattamenti antiblastici all'interno dello studio di implementazione delle linee guida PGx PREPARE 89
Totale 2.367
Categoria #
all - tutte 8.163
article - articoli 7.506
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 3 3 0 26 3 4 9
2021/2022175 2 33 15 7 5 8 18 14 7 7 16 43
2022/2023173 28 20 1 18 29 27 0 14 18 1 16 1
2023/2024166 4 11 18 11 8 38 20 20 2 8 13 13
2024/2025515 3 30 14 25 59 25 31 52 23 29 92 132
2025/20261.100 119 147 265 341 226 2 0 0 0 0 0 0
Totale 2.367